loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2006_281___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Teva API

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TEVA CZECH INDUSTRIES S.R.O. Opava CZ (1)

    filter

    01 Bromocriptine mesilate (1)

    filter

    01 Israel (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    TEVA CZECH INDUSTRIES S.R.O. Opava ...

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothTeva API has over 350 products in its portfolio and is the leading international supplier of APIs.
    Contact Supplier Contact Supplier
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bromocriptine mesilate

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2006-281 - Rev 03
    Valid
    Chemical
    2024-02-05
    596
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2006-281 - Rev 03 of Teva Czech Industries S.r.o. Opava Cz

    Looking for Certificates of Suitability (CEPs) for CEP 2006-281 - Rev 03 of Teva Czech Industries S.r.o. Opava Cz 1

    20

    Teva Czech Industries S.r.o. Opava Cz, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Teva API has over 350 products in its portfolio and is the leading international supplier of APIs.

    One of their significant offerings is Bromocriptine mesilate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2006-281 - Rev 03

    This Chemical Type CEP, issued on February 05, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 596 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY